British Association of Dermatologists' guidelines for the safe and effective prescribing of methotrexate for skin disease 2016

Saved in:
Bibliographic Details
Published inBritish journal of dermatology (1951) Vol. 175; no. 1; pp. 23 - 44
Main Authors Warren, R.B., Weatherhead, S.C., Smith, C.H., Exton, L.S., Mohd Mustapa, M.F., Kirby, B., Yesudian, P.D.
Format Journal Article
LanguageEnglish
Published England Blackwell Publishing Ltd 01.07.2016
Oxford University Press
Subjects
Adult
Alcohol Drinking
Biological Products - adverse effects
Bone Marrow Diseases - chemically induced
Checklist
Chemical and Drug Induced Liver Injury - etiology
Chickenpox - complications
Child
Counseling - methods
Cyclosporine - adverse effects
Dermatologic Agents - adverse effects
Dermatologic Agents - poisoning
Dermatologic Agents - therapeutic use
Drug Administration Routes
Drug Administration Schedule
Drug Approval
Drug Interactions
Drug Monitoring - methods
Drug Overdose - etiology
Evidence-Based Medicine
Female
Hepatitis, Viral, Human - complications
HIV Infections - complications
Humans
Intraoperative Complications - chemically induced
Kidney Diseases - chemically induced
Lung Diseases - chemically induced
Methotrexate
Methotrexate - adverse effects
Methotrexate - poisoning
Methotrexate - therapeutic use
Nausea - chemically induced
Neoplasms - chemically induced
Off-Label Use
Patient Education as Topic - methods
Patient Safety
Pregnancy
Pregnancy Complications - prevention & control
Retinoids - adverse effects
Skin diseases
Skin Diseases - drug therapy
Tuberculosis - complications
Ultraviolet Rays - adverse effects
Vaccination - adverse effects
Online AccessGet full text

Cover

More Information
Bibliography:istex:4818929F1AB4C586953EADC484E8B0B17D22E49C
Data S1. Literature search strategies.
ark:/67375/WNG-QPHS9PTB-R
ArticleID:BJD14816
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Instructional Material/Guideline-2
ObjectType-Feature-3
content type line 23
ISSN:0007-0963
1365-2133
DOI:10.1111/bjd.14816